Compared to bone marrow, HLA-identical transplantation of G-CSF–mobilized PBSCs is associated with sustained protection against relapse and that these benefits are not outweighed by GvHD-related mortality [40]. The gene discussed is CSF3; the disease is graft versus host disease.